D.E. Shaw & Co’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
1,197,624
+79,847
| +7% | +$92.6K | ﹤0.01% | 2080 |
|
|
2025
Q1 | $1.78M | Sell |
1,117,777
-121,682
| -10% | -$193K | ﹤0.01% | 1902 |
|
|
2024
Q4 | $3.76M | Buy |
1,239,459
+110,882
| +10% | +$336K | ﹤0.01% | 1461 |
|
|
2024
Q3 | $4.15M | Buy |
1,128,577
+888,236
| +370% | +$3.27M | ﹤0.01% | 1402 |
|
|
2024
Q2 | $983K | Buy |
240,341
+226,050
| +1,582% | +$925K | ﹤0.01% | 2194 |
|
|
2024
Q1 | $225K | Buy |
+14,291
| New | +$225K | ﹤0.01% | 2719 |
|
|
2023
Q4 | – | Sell |
-37,439
| Closed | -$751K | – | 3392 |
|
|
2023
Q3 | $751K | Buy |
+37,439
| New | +$751K | ﹤0.01% | 2167 |
|
|
2022
Q4 | – | Sell |
-29,112
| Closed | -$631K | – | 3833 |
|
|
2022
Q3 | $631K | Sell |
29,112
-25,633
| -47% | -$556K | ﹤0.01% | 2766 |
|
|
2022
Q2 | $1.54M | Buy |
54,745
+33,786
| +161% | +$949K | ﹤0.01% | 2436 |
|
|
2022
Q1 | $967K | Buy |
20,959
+2,867
| +16% | +$132K | ﹤0.01% | 2895 |
|
|
2021
Q4 | $1.52M | Sell |
18,092
-36,346
| -67% | -$3.06M | ﹤0.01% | 2525 |
|
|
2021
Q3 | $3.63M | Sell |
54,438
-2,016
| -4% | -$134K | ﹤0.01% | 1701 |
|
|
2021
Q2 | $3M | Buy |
56,454
+34,283
| +155% | +$1.82M | ﹤0.01% | 1779 |
|
|
2021
Q1 | $962K | Sell |
22,171
-23,116
| -51% | -$1M | ﹤0.01% | 2213 |
|
|
2020
Q4 | $2.35M | Buy |
45,287
+37,294
| +467% | +$1.94M | ﹤0.01% | 1663 |
|
|
2020
Q3 | $261K | Sell |
7,993
-16,942
| -68% | -$553K | ﹤0.01% | 2320 |
|
|
2020
Q2 | $1.2M | Buy |
+24,935
| New | +$1.2M | ﹤0.01% | 1835 |
|